Form 4: ElectroCore Director Boosts Stake with Share Purchase

A director at electroCore, Inc. has increased their beneficial ownership by purchasing 15,000 shares of common stock.

Summary

• Thomas J. Errico, a Director of electroCore, Inc. (ECOR), purchased 15,000 shares of the company's common stock.
• The transaction occurred on August 11, 2025, at a weighted average price of $4.47 per share, with prices ranging from $4.34 to $4.55.
• Following this acquisition, Mr. Errico's total beneficial ownership in electroCore, Inc. increased to 281,401 shares.
• The total beneficial ownership includes 217,051 shares owned directly, 1,296 shares held by a family trust, 11,000 shares held by a personal trust, 50,672 shares from vested Deferred Stock Units (DSUs), and 1,382 shares issuable from DSUs vesting monthly through September 3, 2025.

Sentiment

Score: 8

Explanation: The sentiment is highly positive due to a significant insider purchase by a director, indicating strong confidence in the company's value and future performance.

Positives

• A director's purchase of company stock signals confidence in the company's future prospects and valuation.
• The acquisition increases insider ownership, which can align management interests with those of shareholders.

Future Outlook

The filing indicates that 1,382 shares issuable pursuant to Deferred Stock Units (DSUs) will continue to vest monthly through September 3, 2025, or earlier upon the company's next annual stockholder meeting or a change of control, provided the reporting person remains in service.

Industry Context

This insider purchase by a director of electroCore, Inc., a company in the medical device sector, suggests internal confidence in the company's strategic direction and product pipeline, particularly its gammaCore non-invasive vagus nerve stimulator.

Related Party Transactions

• The reported transaction is a direct purchase of company stock by a director, which is a related party transaction.

Stakeholder Impact

• Shareholders may view this insider purchase as a positive indicator, potentially increasing investor confidence and demand for the stock.
• Employees may perceive this as a sign of stability and positive outlook from leadership.

Next Steps

• Continued monthly vesting of 1,382 Deferred Stock Units (DSUs) through September 3, 2025, or earlier upon the Issuer's next annual stockholder meeting or a change of control.

Key Dates

Recommendation

The significant purchase of common stock by a director at electroCore, Inc. signals strong insider confidence in the company's valuation and future prospects. Such insider buying often precedes positive developments or reflects a belief that the stock is undervalued, making it a compelling 'buy' signal for seasoned investors.

Keywords

electroCore, ECOR, Insider Trading, Director Purchase, Stock Acquisition, Form 4, Beneficial Ownership, Medical Devices